Elder Pharma has been a major under-performer for the last two months on back of fears of major management shift in the company.
The stock today touched a fresh 52-week low of Rs. 127, and has slumped a whopping 29 per cent in the last one month so far.
According to releases issued by the company to the BSE since November 12, 2014, as many as five directors - three Non-Executive - Independent Directors - Saleem Shervni, Jayaram Subramanian and Urvashi Saxena along with one Additional Director Farid R. Gulmohamedand one Executive Director Yusuf Karim Khan have resigned from the company.
Further the company on request has been granted extension of time for holding 31st Annual General Meeting upto March 30, 2015 (3 months) by Registrar of Companies.
The stock is now down over 3 per cent at Rs. 128. The counter has seen trades of around 9,250-odd shares as against the two-week daily average volume of around 20,000 shares on the BSE.
Meanwhile, the Sensex is now down 32 points at 27,318.
The stock today touched a fresh 52-week low of Rs. 127, and has slumped a whopping 29 per cent in the last one month so far.
According to releases issued by the company to the BSE since November 12, 2014, as many as five directors - three Non-Executive - Independent Directors - Saleem Shervni, Jayaram Subramanian and Urvashi Saxena along with one Additional Director Farid R. Gulmohamedand one Executive Director Yusuf Karim Khan have resigned from the company.
Further the company on request has been granted extension of time for holding 31st Annual General Meeting upto March 30, 2015 (3 months) by Registrar of Companies.
The stock is now down over 3 per cent at Rs. 128. The counter has seen trades of around 9,250-odd shares as against the two-week daily average volume of around 20,000 shares on the BSE.
Meanwhile, the Sensex is now down 32 points at 27,318.
No comments:
Post a Comment